Go Pro
OTCMKTS:ERFSF

Eurofins Scient (ERFSF) Stock Price, News & Analysis

Eurofins Scient logo
$79.03 +1.23 (+1.58%)
As of 03:56 PM Eastern

About Eurofins Scient Stock (OTCMKTS:ERFSF)

Advanced

Key Stats

Today's Range
$77.68
$80.34
50-Day Range
$68.80
$80.99
52-Week Range
$64.95
$86.20
Volume
566 shs
Average Volume
4,707 shs
Market Capitalization
$14.98 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Hold

Company Overview

Eurofins Scientific is a global provider of bioanalytical testing and laboratory services, offering a wide array of testing solutions to pharmaceutical, food, environmental, agriscience and consumer products industries. Its core services include pharmaceutical quality control, environmental testing for water and air quality, food safety analysis, agrochemical trials and clinical diagnostic support. The company operates specialized laboratories equipped with advanced analytical technologies such as chromatography, mass spectrometry and molecular biology to ensure compliance with regulatory standards and to support research and development efforts across multiple sectors.

Founded in 1987 by Gilles Martin and headquartered in Luxembourg, Eurofins has grown through a combination of organic expansion and strategic acquisitions. The firm now serves clients in more than 50 countries, operating over 900 laboratories worldwide. This extensive network enables Eurofins to provide locally tailored testing solutions while maintaining a consistent global quality framework. Its geographic footprint covers Europe, North America, Asia-Pacific, Latin America and the Middle East, allowing it to meet regional regulatory requirements and support multinational projects.

Eurofins places a strong emphasis on innovation and scientific excellence, investing in research initiatives and developing proprietary methods to address emerging analytical challenges. The company collaborates with academic institutions, regulatory agencies and industry partners to advance testing protocols and promote best practices in laboratory science. Eurofins’ interdisciplinary teams of scientists, engineers and technical specialists ensure the continuous enhancement of service quality and the rapid deployment of novel testing methodologies.

Leadership at Eurofins is led by founder and Chief Executive Officer Gilles Martin, who has guided the company’s transformation from a single laboratory into a diversified network of testing services. Under his direction, Eurofins has built a culture of scientific rigor, customer focus and entrepreneurial growth. The management team comprises experienced executives in operations, finance and scientific development, driving strategic initiatives to expand the company’s capabilities and global reach.

AI Generated. May Contain Errors.

Eurofins Scient Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
5th Percentile Overall Score

ERFSF MarketRank™: 

Eurofins Scient scored higher than 5% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Eurofins Scient has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on no strong buy ratings, 1 buy rating, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Eurofins Scient has received no research coverage in the past 90 days.

  • Read more about Eurofins Scient's stock forecast and price target.
  • Price to Book Value per Share Ratio

    Eurofins Scient has a P/B Ratio of 2.62. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.14% of the float of Eurofins Scient has been sold short.
  • Short Interest Ratio / Days to Cover

    Eurofins Scient has a short interest ratio ("days to cover") of 24.36, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Eurofins Scient has recently increased by 7.79%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Eurofins Scient does not currently pay a dividend.

  • Dividend Growth

    Eurofins Scient does not have a long track record of dividend growth.

  • News Sentiment

    Eurofins Scient has a news sentiment score of 0.48. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.87 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Eurofins Scient this week, compared to 2 articles on an average week.
Receive ERFSF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Eurofins Scient and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ERFSF Stock News Headlines

Eurofins Scientific: Director/PDMR Shareholding
Eurofins Scientific: Director/PDMR Shareholding
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow.tc pixel
Eurofins Scientific: Director/PDMR Shareholding
Eurofins Scientific: Director/PDMR Shareholding
See More Headlines

ERFSF Stock Analysis - Frequently Asked Questions

Eurofins Scient's stock was trading at $73.28 at the beginning of 2026. Since then, ERFSF shares have increased by 7.8% and is now trading at $79.0250.

Shares of ERFSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
7/31/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Healthcare Providers & Services
Sub-Industry
N/A
Current Symbol
OTCMKTS:ERFSF
Previous Symbol
NASDAQ:ERFSF
CIK
N/A
Employees
62,696
Year Founded
1987

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$8.25 billion
Price / Sales
1.82
Cash Flow
$7.09 per share
Price / Cash Flow
11.14
Book Value
$30.19 per share
Price / Book
2.62

Miscellaneous

Outstanding Shares
189,622,000
Free Float
N/A
Market Cap
$14.98 billion
Optionable
Not Optionable
Beta
0.59

Social Links

7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (OTCMKTS:ERFSF) was last updated on 7/31/2026 by MarketBeat.com Staff.
From Our Partners